nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ALB—Acetylsalicylic acid—Kawasaki disease	0.417	0.436	CbGbCtD
Naloxone—CYP2C8—Acetylsalicylic acid—Kawasaki disease	0.322	0.337	CbGbCtD
Naloxone—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.218	0.228	CbGbCtD
Naloxone—TLR4—heart—Kawasaki disease	0.00764	0.232	CbGeAlD
Naloxone—CREB1—cardiac ventricle—Kawasaki disease	0.00512	0.155	CbGeAlD
Naloxone—CREB1—neck—Kawasaki disease	0.00509	0.154	CbGeAlD
Naloxone—CREB1—heart—Kawasaki disease	0.00336	0.102	CbGeAlD
Naloxone—CREB1—skin of body—Kawasaki disease	0.00329	0.0998	CbGeAlD
Naloxone—ALB—gall bladder—Kawasaki disease	0.00309	0.0936	CbGeAlD
Naloxone—ESR1—neck—Kawasaki disease	0.002	0.0607	CbGeAlD
Naloxone—ALB—heart—Kawasaki disease	0.00155	0.047	CbGeAlD
Naloxone—ESR1—heart—Kawasaki disease	0.00132	0.0401	CbGeAlD
Naloxone—TLR4—Spinal Cord Injury—FCGR2A—Kawasaki disease	0.000751	0.0719	CbGpPWpGaD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—CD40—Kawasaki disease	0.00068	0.0651	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—ITPKC—Kawasaki disease	0.000648	0.0621	CbGpPWpGaD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—CD40—Kawasaki disease	0.000531	0.0508	CbGpPWpGaD
Naloxone—ABCB1—heart—Kawasaki disease	0.000523	0.0158	CbGeAlD
Naloxone—ESR1—Integrated Breast Cancer Pathway—ITPKC—Kawasaki disease	0.000425	0.0407	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—BLK—Kawasaki disease	0.000297	0.0285	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—IL10—Kawasaki disease	0.000246	0.0235	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—MMP9—Kawasaki disease	0.000229	0.022	CbGpPWpGaD
Naloxone—CREB1—Regulation of nuclear SMAD2/3 signaling—IL10—Kawasaki disease	0.000219	0.0209	CbGpPWpGaD
Naloxone—OPRD1—Peptide GPCRs—CCR5—Kawasaki disease	0.000212	0.0203	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—FCGR2A—Kawasaki disease	0.000211	0.0202	CbGpPWpGaD
Naloxone—OPRM1—IL4-mediated signaling events—IL10—Kawasaki disease	0.0002	0.0192	CbGpPWpGaD
Naloxone—OPRK1—Peptide GPCRs—CCR5—Kawasaki disease	0.000186	0.0178	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000182	0.0174	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—BLK—Kawasaki disease	0.00017	0.0163	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—IL10—Kawasaki disease	0.000161	0.0154	CbGpPWpGaD
Naloxone—OPRM1—Peptide GPCRs—CCR5—Kawasaki disease	0.000157	0.015	CbGpPWpGaD
Naloxone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—Kawasaki disease	0.000143	0.0137	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000134	0.0129	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL10—Kawasaki disease	0.00013	0.0124	CbGpPWpGaD
Naloxone—TLR4—Immune System—FCGR2A—Kawasaki disease	0.000123	0.0118	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—Kawasaki disease	0.000122	0.0117	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—MMP9—Kawasaki disease	0.000122	0.0116	CbGpPWpGaD
Naloxone—TLR4—Immune System—BLK—Kawasaki disease	0.000119	0.0114	CbGpPWpGaD
Naloxone—CREB1—Oncostatin M Signaling Pathway—VEGFA—Kawasaki disease	0.000116	0.0111	CbGpPWpGaD
Naloxone—CREB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000114	0.011	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—CD4—Kawasaki disease	0.000114	0.0109	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CRP—Kawasaki disease	0.00011	0.0105	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—CRP—Kawasaki disease	0.000105	0.0101	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.000101	0.00966	CbGpPWpGaD
Naloxone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—Kawasaki disease	0.0001	0.00958	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—CCR5—Kawasaki disease	9.98e-05	0.00955	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD40—Kawasaki disease	9.91e-05	0.00948	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—CCR5—Kawasaki disease	8.75e-05	0.00837	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—CRP—Kawasaki disease	8.57e-05	0.00821	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—CD4—Kawasaki disease	8.44e-05	0.00808	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—CCR5—Kawasaki disease	8.42e-05	0.00805	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ITPKC—Kawasaki disease	8.09e-05	0.00774	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—MMP9—Kawasaki disease	7.97e-05	0.00763	CbGpPWpGaD
Naloxone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	7.81e-05	0.00747	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL10—Kawasaki disease	7.74e-05	0.00741	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—CD4—Kawasaki disease	7.4e-05	0.00709	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—CCR5—Kawasaki disease	7.39e-05	0.00708	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—CCR5—Kawasaki disease	7.38e-05	0.00706	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—FCGR2A—Kawasaki disease	7.37e-05	0.00705	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—MMP9—Kawasaki disease	6.95e-05	0.00665	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—BLK—Kawasaki disease	6.86e-05	0.00657	CbGpPWpGaD
Naloxone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	6.85e-05	0.00655	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—CRP—Kawasaki disease	6.81e-05	0.00652	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	6.69e-05	0.0064	CbGpPWpGaD
Naloxone—TLR4—Immune System—CRP—Kawasaki disease	6.38e-05	0.00611	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—CCR5—Kawasaki disease	6.24e-05	0.00597	CbGpPWpGaD
Naloxone—CREB1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	5.91e-05	0.00565	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	5.87e-05	0.00562	CbGpPWpGaD
Naloxone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	5.79e-05	0.00554	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—VEGFA—Kawasaki disease	5.75e-05	0.00551	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD40—Kawasaki disease	5.7e-05	0.00546	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—CCR5—Kawasaki disease	5.1e-05	0.00488	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	4.96e-05	0.00475	CbGpPWpGaD
Naloxone—CREB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	4.89e-05	0.00468	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—CCR5—Kawasaki disease	4.47e-05	0.00428	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD4—Kawasaki disease	4.31e-05	0.00413	CbGpPWpGaD
Naloxone—CREB1—Immune System—FCGR2A—Kawasaki disease	4.29e-05	0.00411	CbGpPWpGaD
Naloxone—CREB1—Immune System—BLK—Kawasaki disease	4.16e-05	0.00398	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ITPKC—Kawasaki disease	3.97e-05	0.0038	CbGpPWpGaD
Naloxone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	3.97e-05	0.0038	CbGpPWpGaD
Naloxone—ALB—Metabolism—ITPKC—Kawasaki disease	3.95e-05	0.00378	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—VEGFA—Kawasaki disease	3.88e-05	0.00372	CbGpPWpGaD
Naloxone—ESR1—Integrated Breast Cancer Pathway—VEGFA—Kawasaki disease	3.87e-05	0.0037	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CRP—Kawasaki disease	3.83e-05	0.00366	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—CCR5—Kawasaki disease	3.78e-05	0.00361	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	3.7e-05	0.00354	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—MMP9—Kawasaki disease	3.57e-05	0.00342	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ITPKC—Kawasaki disease	3.46e-05	0.00331	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD40—Kawasaki disease	3.46e-05	0.00331	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	3.44e-05	0.00329	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—VEGFA—Kawasaki disease	3.21e-05	0.00307	CbGpPWpGaD
Naloxone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	3.21e-05	0.00307	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—CCR5—Kawasaki disease	2.88e-05	0.00276	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—CCR5—Kawasaki disease	2.62e-05	0.00251	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—CCR5—Kawasaki disease	2.61e-05	0.0025	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CD4—Kawasaki disease	2.58e-05	0.00247	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—Kawasaki disease	2.55e-05	0.00244	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—CCR5—Kawasaki disease	2.52e-05	0.00242	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD4—Kawasaki disease	2.48e-05	0.00238	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—CCR5—Kawasaki disease	2.29e-05	0.00219	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—VEGFA—Kawasaki disease	2.29e-05	0.00219	CbGpPWpGaD
Naloxone—CREB1—Immune System—CRP—Kawasaki disease	2.23e-05	0.00213	CbGpPWpGaD
Naloxone—CREB1—Disease—CCR5—Kawasaki disease	2.21e-05	0.00212	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—CCR5—Kawasaki disease	2.13e-05	0.00204	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ITPKC—Kawasaki disease	2.13e-05	0.00204	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—CCR5—Kawasaki disease	1.94e-05	0.00185	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	1.72e-05	0.00165	CbGpPWpGaD
Naloxone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	1.7e-05	0.00162	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—CCR5—Kawasaki disease	1.55e-05	0.00148	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—CCR5—Kawasaki disease	1.54e-05	0.00148	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD4—Kawasaki disease	1.51e-05	0.00144	CbGpPWpGaD
Naloxone—CREB1—Disease—CD4—Kawasaki disease	1.39e-05	0.00133	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—CCR5—Kawasaki disease	1.35e-05	0.0013	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—CCR5—Kawasaki disease	1.14e-05	0.0011	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—CCR5—Kawasaki disease	1.01e-05	0.000971	CbGpPWpGaD
Naloxone—ALB—Hemostasis—VEGFA—Kawasaki disease	8.88e-06	0.00085	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—Kawasaki disease	8.47e-06	0.000811	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—Kawasaki disease	8.45e-06	0.000808	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—VEGFA—Kawasaki disease	7.61e-06	0.000728	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—VEGFA—Kawasaki disease	7.58e-06	0.000726	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—Kawasaki disease	7.41e-06	0.000709	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—VEGFA—Kawasaki disease	6.65e-06	0.000637	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—Kawasaki disease	6.26e-06	0.000599	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—VEGFA—Kawasaki disease	5.62e-06	0.000538	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—Kawasaki disease	5.55e-06	0.000531	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—VEGFA—Kawasaki disease	4.98e-06	0.000477	CbGpPWpGaD
